SCHEMBL3573000

SCHEMBL3573000

NC(=O)N(c1ccc(Cl)cc1)C(C(=O)O)c1ccccc1Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.44
SLC1A5 Q15758 1/20 0.42
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
CTNNB1 P35222 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
PNLIP P16233 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 4/20 0.38
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566188 0.88 ATM (0.45) L3MBTL1ALDH1A1HPGDHTTATM
SCHEMBL3569468 0.83 CYP11B1 (0.39) PPARASLC1A5PNLIPPPARG
SCHEMBL3563022 0.82 MDM2 (0.41) PPARASLC6A4L3MBTL1ALDH1A1ATM
SCHEMBL3563412 0.80 PPARA (0.38) PPARAALDH1A1GAAHTTATM
SCHEMBL3564244 0.80 CES2 (0.36) PPARAL3MBTL1ALDH1A1GAAATM
SCHEMBL3569300 0.80 CNR2 (0.41) PPARAALDH1A1GAAMEN1KMT2A
SCHEMBL3557436 0.80 PPARG (0.38) PPARAALDH1A1PPARGMAPT
SCHEMBL3566089 0.78 PCTP (0.36) L3MBTL1ALDH1A1GAAHPGDHTT
SCHEMBL3568466 0.77 TRPM8 (0.41) ALDH1A1GAAMEN1KMT2ACYP1A2
SCHEMBL3573308 0.76 F10 (0.39) L3MBTL1ALDH1A1GAAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678913-B2 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2010-03-16 US disclosed
US-20060160821-A1 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US disclosed
WO-2006063113-A2 UREAS AS FACTOR XA INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160821-A1 Ureas as factor Xa inhibitors TFPI, F12, F11 PPARA 4457/4885SLC1A5 1060/4885HTR2A 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.